EFC Congress 2026

Abstracts

The European Federation for Colposcopy is pleased to open abstract submissions.

ABSTRACT SUBMISSION

The Scientific Committee invites attendees to actively participate in this Congress which will be a very significant occasion for the exchange of thoughts and experiences.

ABSTRACT SUBMISSION IS NOW CLOSED

All abstracts must be submitted through the online system on the Congress website and should be prepared in accordance to the instructions below.
Please read carefully and download the following instructions before proceeding with the online submission.

Authors should select their presentation preference: oral presentation or free communication. Once your abstract has been approved, it will be considered by the selection committee, which will select the 20 best submissions for oral presentation. The committee reserves the right to reclassify any accepted abstract as a poster/free communication rather than an oral presentation.

For the oral presentation, authors will have 7 minutes for their oral presentation during the plenary session. For the free communication, the selected abstracts will be presented as e-posters through projection in the Exhibition Hall. No oral presentation will be required.

Please note that registration for the Congress is mandatory for the first author of all selected abstracts (both oral presentations and free communications). Abstracts will not be displayed or presented at the Congress unless the first author is registered.

DOWNLOAD ABSTRACT SUBMISSION GUIDELINES HERE

ABSTRACT TOPICS

For review purposes, abstracts are classified according to the following list.

Please select only 1 topic:

Basic research in HPV and cervical cancer (genomics, immunology, carcinogenesis)
Cervical cancer screening (HPV testing, cervical cytology, molecular markers)
Colposcopy
HPV vaccination
Management of SIL/ AIS (CIN and CGIN) (follow-up, treatment)
Miscellaneous and case reports
Quality assurance
STDs and HIV
Training and education in colposcopy
Vaginal microbiome and HPV
Vulvo-vaginal disease including SIL (and AIN)

Abstracts Oral Presentations

Best oral presentation

Alexander Englisch – Age-specific CIN3+ rates in low-grade cytology and persistent HPV referrals compared with a high-grade cytology reference: real-world data from Germany’s organised cervical screening programme

1	Alexander Englisch	Age-specific CIN3+ rates in low-grade cytology and persistent HPV referrals compared with a high-grade cytology reference: real-world data from Germany’s organised cervical screening programme
9	Cecilia Karrberg	Quadrivalent HPV vaccination before pregnancy and the risk of adverse pregnancy outcomes
13	Covadonga Castro Díaz	Role of self-sampling in population-based cervical cancer screening: experience in a high-income country region
14	Cristian Bucsineanu	Implementation of an integrated cervical screening pathway based on HPV self-collection in a population from North-East Romania: feasibility, acceptability and clinical performance
19	Efraim Siegler	HR-HPV negative after LLETZ of Early-Stage Cervical Cancer and AIS has a high correlation with absence of malignancy
25	Gabi Haran	HPV 16 Confers a 6.65-Fold Adjusted CIN2+ Risk at Colposcopy Independent of Cytology: Evidence from 11,307 Women with Documented HPV Status
26	Gabi Haran	Six-Year Colposcopy Programme Trends in an Israeli HRHPV Screening Era: 86% Volume Growth, Post-COVID Peak, and Referral-Pool Dilution – 47,331 Visits 2020 to 2026
35	Gianmarco Sartini	Quantifying the Incremental Contribution of Colposcopy to CIN2+ Risk Estimation Using Bayesian Latent Class Analysis
36	Camilla Cicoli	Mapping Colposcopy Training, Assessment and Certification Across Europe: An EFC Member Society Survey
41	Ivana Nakov	Efficacy of AI-Assisted Colposcopy in Minimizing Overtreatment During Primary HPV Screening: A Systematic Review and Meta-Analysis
46	Laurent Bélec	Large-scale pilot feasibility evaluation of veil-based self-sampling of cervicovaginal specimens accessible through dedicated digital logistic platform for integrated screening of HR-HPV and sexually transmitted infections
47	Leon Henes	Impact of colposcopic findings on HSIL+ rates: The role of transformation zone visibility
48	Leonardo Natalini	Can Large Language Models (LLMs) make colposcopy easy to read? An exploratory case study on simplified colposcopic reports
49	Leonor Aguiar	Breakthrough High-Grade Cervical Lesions After Pre-Coitarche Quadrivalent HPV Vaccination: Genotype Distribution, Histopathology and Post-Conization Outcomes
52	Ludmila Velenciuc	The psychological impact of cervical dysplasia diagnosis on women’s quality of life
55	Marco Bernardi	From Knowledge Gaps to Guideline-Concordant Decisions: Educational Impact of a National Webinar on Colposcopy During Pregnancy
70	Rosemary Harkin	What happens to women over 50 referred to colposcopy?
75	Tamar Alibegashvili	Transitioning from cytology to HPV testing: first results of national screening in Georgia
85	Yael Barkan	Extended HPV Genotyping for Risk Stratification in Cervical Screening: A Population-Based Study
86	Yuliia Mazur	Why do women not attend cervical cancer screening? Preliminary findings from a cross-sectional survey in the Lviv region (Ukraine)

Abstracts Posters

Best poster

Antonina Bednarek – National benchmarking as quality assurance: nineteen years of Scotland’s Colposcopy Clinical Information and Audit System

2	Alexandroaie Ioana	Endometriosis and Cervical Dysplasia: Current Evidence and Ongoing Systematic Review of Colposcopic, Histopathologic and Immunologic Findings
3	Alina Sinziana Melinte Popescu	Normal Cytology–HPV-Positive Discordance in Colposcopy Patients: Prevalence, Colposcopic Outcomes, and Role of Prior Dysplasia
4	Alina Sinziana Melinte Popescu	Persistent HPV45 Infection and Recurrent Atypical Glandular Cytology Despite Negative Investigations Revealing Occult Endocervical Adenocarcinoma In Situ
5	Anca-Maria Istrste-Ofiteru	When NILM Is Not Reassuring: HPV16-Positive Patient with an Extensive Cervical Lesion Revealing Invasive Cervical Carcinoma
6	Antonina Bednarek	National benchmarking as quality assurance: nineteen years of Scotland’s Colposcopy Clinical Information and Audit System
7	Catarina Alves	Histological HSIL in Women Younger Than 30 Years: HPV Vaccination Status in a Tertiary Referral Colposcopy Centre
8	Catarina Alves	Real-World Outcomes of Histological HSIL in Women Younger Than 30 Years: Experience from a Tertiary Referral Colposcopy Centre
10	Claudia Cocollini	Cervical dysplasia in unscreened cervices of patients with OHVIRA syndrome: a case series
11	Codreanu Nadejda	High-Risk HPV Testing Reveals Cervical Precancer Risk Beyond Cytology Alone
12	Costin Robert	Post-Vaccination Immunity as a Predictor of HPV Persistence After LEEP
16	Cristina Elena Mandici	Cervical Endometriosis Mimicking a High-Grade Cervical Lesion: A Rare Colposcopic Diagnosis – Case Report
17	DINU MARINA	HPV Infection in Young Women: An Emerging Challenge for Colposcopy
18	Edu Mihnea	Human DNA Methylation as a Complementary Tool to Colposcopy in the Evaluation of HPV-Associated Cervical Lesions
20	Eligija Teleišytė	Colposcopy Quality Assessment Using European Federation for Colposcopy Standards: A Single-Centre Audit
23	Erdelean Izabella	Beyond HPV: The Emerging Role of DNA Methylation in Cervical Cancer Prevention and Patient Triage
24	Filomena Silveira	Gastric-Type Endocervical Adenocarcinoma In Situ (HPV-Independent) Associated with a Squamous Precursor Lesion: A Case Report
27	Gabi Haran	Postcoital Bleeding CIN2+ Risk Is Not Determined by the Symptom: A 50-Fold Range from 1.1% to 56.2% by HPV Genotype and Cytology in 4,960 Biopsies
28	Gabi Haran	Smoking Amplifies CIN2+ Risk Specifically in HPV 16-Positive Women: Genotype-Dependent Synergy in 5,013 Biopsy Records
29	Gina Vich	EFFECTIVENESS OF A CORIOLUS VERSICOLOR-BASED VAGINAL GEL ON HIGH-RISK HPV CLEARANCE IN AN IMMUNOCOMPROMISED POPULATION: PRELIMINARY RESULTS OF A PROSPECTIVE COHORT STUDY.
30	Gina Vich	A CORIOLUS VERSICOLOR-BASED VAGINAL GEL EFFICACY ON HR-HPV CLEARANCE: FINAL RESULTS FROM PAPILOCAN CLINICAL TRIAL
31	Gina Vich	PREVENTION OF POST-CONIZATION CERVICAL STENOSIS WITH A CORIOLUS VERSICOLOR-BASED VAGINAL GEL: A POST-HOC ANALYSIS OF A PILOT STUDY
32	Gina Vich	PRELIMINARY RESULTS ON A CORIOLUS VERSICOLOR-BASED VAGINAL GEL FOR CERVICAL HEALING AND HR-HPV CLEARANCE POST-CONIZATION
33	Gina Vich	HR-HPV CLEARANCE WITH A CORIOLUS VERSICOLOR-BASED VAGINAL GEL IN WOMEN OVER 40 YEARS: POOLED RESULTS FROM THE PALOMA 1 AND 2 RANDOMIZED CLINICAL TRIALS.
34	Gina Vich	INITIAL ASSESSMENT OF A CORIOULS VERSICOLOR-BASED ANAL GEL FOR THE TREATMENT OF LOW-GRADE ANAL INTRAEPITHELIAL LESIONS
38	Ioana Păvăleanu	Cervical Transformation Zone: A Universal Model of Epithelial Metaplasia and Carcinogenesis
39	Irina Liviana Stoian	Losing the protective Lactobacillus: a cervicovaginal microbiota signature behind Romania’s highest-in-EU cervical cancer burden
40	Irina Liviana Stoian	Compliance with post-excisional monitoring of cervical dysplastic lesions: a retrospective study in North-Eastern Romania
42	Jesús de la Fuente Valero	Tailored HPV vaccination counselling improves vaccine uptake among adult women by addressing the main barrier: lack of healthcare professional recommendation
45	Laura Coca	LEGISLATIVE OPPORTUNITY VERSUS REALITY IN THE FIELD: LOCAL SOLUTIONS FOR INCREASING HPV VACCINE COVERAGE.
50	LILIANA STRAT	HPV Infection in Pregnancy: Is Screening Needed? Review of the Guidelines.
51	LILIANA STRAT	Risks of HPV Infection in Pregnancy: Hypotheses in the Literature
53	Ludmila Velenciuc	Management of High-Grade Cervical Dysplasia in Uterine Didelphys: The Challenges of Bilateral Evaluation and Treatment
54	Magdalena Petrache	Cervical Neuroendocrine Small Cells Carcinoma Case Report
56	Maria Castro sanchez	FROM GUIDELINES TO REALITY: LESSONS LEARNED IMPLEMENTING A EUROPEAN CERVICAL CANCER SCREENING PROJECT IN UGANDA
60	Mihaela Bot	Beyond the Cervix: The Role of Vaginoscopy in the Evaluation of Vaginal Intraepithelial Lesions
61	Mihaela Camelia Tirnovanu	Risk factors for positive margins after the large loop excision of the transformation zone procedure
62	MIHOCI ANA-MARIA	Public versus Private Cervical Cancer Screening: Differences in the Detection of Cervical Cytological Abnormalities
66	oladayo oduola	Management of Women Aged ≥65 Years in Colposcopy Services Following Introduction of HPV Primary Screening in Ireland: A Service Evaluation
67	oladayo oduola	Hysterectomy After Recurrent/Persistent HPV (HARP Study)
68	Raffaella Venzi	COLPOSCOPIC MAGNIFIED SCANNING Assisted CO2 LASER TREATMENTS (CMSLT) for High Grade Vaginal Intraepithelial Neoplasia /vaHSIL: a single center prospective cohort study
69	Ramya Baskaran	DIAGNOSING RECURRRENT VULVAL BCC IN A 53-YEAR-OLD
72	SHAHAD MAHMOUD HUSSEIN MAHMOUD	Prevalence of HPV, and genotype distribution in women screened at Sheikh Shakhbout Medical City, a Tertiary Hospital in Abu Dhabi, United Arab Emirates (UAE)
74	Simender Mesci	CHLAMYDIA TRACHOMATIS AS A CO-FACTOR IN HPV PERSISTENCE: THE CLINICAL RATIONALE FOR COMBINED VACCINES
76	Tănase Adina Elena	Customizing treatment for nulliparity with HPV 16 positive result
77	Tănase Adina Elena	How to manage cervical lesion suspicions associated with normal Pap smear
78	Tănase Adina Elena	COLPOSCOPY AND CERTAIN DEGREES OF CERVICAL DISPLASIA IN YOUNG FEMALES
79	Tănase Adina Elena	How to manage endocervical glandular lesions
80	THINOSHINI NAIR RAMANKUTTI	Comparing effectiveness of treatments in women of reproductive age – a local comparative cohort study
82	Tudor Catalin Gisca	Cervico-vaginal dysbiosis and its association with FAM19A4 and miR-124-2 promoter methylation in cervical intraepithelial neoplasia
83	Tudor Catalin Gisca	Evaluation of Modifiable Risk Factors in Postmenopausal Women Undergoing Cervical Conization for Precancerous Cervical Lesions: A Literature Review
84	Vesna Krsic	The role of infection with Ureplasma urelayticum and Mycoplasma hominis in developing CIN 2+ lesions
88	Zakia Mohammed Habib Habib	LAST CASE PRESENTATION

Tickets

Register for EFC Congress 2026

11th European Federation For Colposcopy Congress
“Cervical cancer prevention and colposcopy”